ikool
2021-07-29

$NRX Pharmaceuticals Inc.(NRXP)$

As we wait patiently FDA approval. ⬇️

"To our knowledge this is the first demonstration of clinically and statistically-significant benefit by any therapeutic agent in patients with COVID-19 respiratory failure in a randomized, double blind, prospective trial….. ZYESAMI, if authorized, would be the first drug for such critically ill patients. $nrxp

免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白
发表看法
2